Brief: Lansen Pharmaceutical Says Group's HY Revenue Expected To Record A Moderate Decrease

Lansen Pharmaceutical Holdings

29/07/2021 11:47

July 29 (Reuters) - Lansen Pharmaceutical Holdings Ltd
 0503.HK :
    * GROUP'S REVENUE IS EXPECTED TO RECORD A MODERATE DECREAS
FOR SIX
MONTHS
    * GROUP'S OPERATING PROFIT IS EXPECTED TO RECORD A
SIGNIFICANT
DECREASE FOR SIX MONTHS
    * OPERATING PROFIT IS EXPECTED TO RECORD SIGNIFICANT
DECREASE FOR
HY
    * GROUP'S NET PROFIT IS EXPECTED TO RECORD A SIGNIFICANT
DECREASE
FOR SIX MONTHS
    * NET PROFIT IS EXPECTED TO RECORD SIGNIFICANT DECREASE FOR
HY
    * EXPECTED DECREASE IN REVENUE DUE TO DECREASE IN SALES
VOLUME OF
GROUP'S CORE PRODUCTS
    * EXPECTED DECREASE IN NET PROFIT FROM ONE-OFF NET INCOME
ARISING
FROM RECLASSIFICATION OF INTEREST IN STARRY AS FINANCIAL ASSETS


Further company coverage:  0503.HK 

 ((Reuters.Briefs@thomsonreuters.com;))